Friday, November 25, 2005 7:54:27 PM
"Have you even considered the possibility..."
Of course I have. Personally not knowing any of these entities that have been acquired, I chose to instead defer to both stockboy and hopeful107's assertion that the cost of salaries of the employees of these acquisitions would/will be exorbitant and merely responded to that assertion.
"How is DNAG going to pay all of these newly acquired companies salaries?"
"Lets say 5 Million for Kenna + 5 Million for Trace + 10 Million for Ellipsis Biotherapeutics salarys would = 20 Million a year just in salarys. Does the combined revenue come to 20 Million BECAUSE IF ITS DOES NOT guess what Dnaprint pays the Bill."
Your purposed hypothesis, on the other hand;
"...the supposed "bright minds" you are referring to never really had any flourishing businesses to begin with, so the acquisition of their companies by DNAG with its toxic financing and 1.5 billion a/s will at least assure the principals of compensation packages and bonuses, for perhaps years to come at DNAG shareholders' expense, that they could not enjoy from their original companies?"
...clearly implies the possibility of malfeasance or possibly conspiracy of same. As such, as well as my being not in a position to prove otherwise, I will now defer to you. My position still stands however. I cannot see the logic of several companies willing to be acquired even under your supposition of compensatory skulduggery. Most if not all investment of DNAG has come from internet buyers. This stock is not on any Wallstreet screen. As such, the buyers {including you, me, and everybody here in DNAG-land} have not let this stock rebound from the R/S. If I'm an entity looking for a corporate sugar daddy I'm sure I'd be looking for a more riper fledging company to piggy-back onto. You know, one that has a smaller float, less press, something that daytraders and front-runners could ride into REAL profit gains.
Not knowing, however, we will have to wait and see...
Theo
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM